ANVISA
Anvisa Collegiate Board has new composition defined after director's departure
Anvisa approves new framework for herbal medicines in Brazil
RDC 327 review rapporteur bids farewell to Anvisa this Friday (19).
Researchers submit technical proposal to Anvisa for cannabis regulation
CFF advocates for magistral manipulation amid changes in Cannabis regulation
16/12/2025Entity reinforces that personalized preparations are essential when industrialized products do not meet clinical needs
Cannabis cultivation and regulatory review take center stage in the 2026–2027 Regulatory Agenda
15/12/2025Approved document defines 161 priority topics for the next two years, including national cultivation of low-THC cannabis
CRF-SP warns of risk of setback and legal uncertainty in the review of the Cannabis regulation
15/12/2025According to Marcelo Polacow Bisson, excluding pharmacies' manipulation leads to lack of assistance; Anvisa's proposed text on the Cannabis regulation is also criticized for bypassing procedural rites
Proposal to restrict Cannabis importation (RDC 660) sparks reaction in the market
12/12/2025Proposal in the review of RDC 327/2019 to RDC 660/2022 divides opinions and raises doubts about access and judicialization
RDC 327 vote postponed at Anvisa; ABIQUIFI evaluates new deadline as "legitimate tool"
11/12/2025Brazilian Association of Pharmaceutical Inputs Industry trusts that director Thiago Campos' request for review will result in a more thorough analysis, maintaining the expectation of regulatory framework completion in January 2026
Deadline: Anvisa receives studies on cannabis cultivation until this Friday
11/12/2025The submission of scientific evidence is essential to support the regulation of cannabis cultivation in Brazil and complies with STJ's determination
Anvisa suspends review of RDC 327 after director's request for further analysis
10/12/2025Rapporteur Rômison Mota advocated for changes impacting imports via RDC 660; new rule prioritizes national products when there is equivalence
Anvisa suspends review of RDC 327 after director's request for further analysis
10/12/2025Rapporteur Rômison Mota advocated for changes impacting imports via RDC 660; new rule prioritizes national products when there is equivalence
Anvisa to decide today the future of RDC 327 in a meeting that could redefine rules for cannabis products in Brazil
10/12/2025Norm that regulates manufacturing, importation, prescription, and inspection may be entirely revoked and replaced by a new regulatory framework; decision will be made at the Collegiate Board meeting.
Anvisa grants sanitary authorization for new cannabidiol product from pharmaceutical company
08/12/2025Publication in the Official Gazette of this Monday (8) details the approval of the 100 mg/ml oral solution
Anvisa warns of deadline for comments on agenda including review of RDC 327/2019
04/12/2025Submission of registrations, videos, and requests for confidentiality ends at 11:59 pm this Friday (5); item revising rules for cannabis products will be defined at the Dicol meeting on December 10
Anvisa receives studies on Cannabis cultivation until December 12
01/12/2025Public call aims to gather scientific evidence to support the regulation of Cannabis cultivation for medicinal and pharmaceutical purposes in Brazil